Champagne Approves Its First Disease-Resistant Grape

Champagne, the French region whose name has long stood for continuity and strict rules, has authorized a disease-resistant grape variety for the first time in its modern history, a move that reflects how one of the world’s most closely guarded wine appellations is beginning to adapt to climate pressure, fungal disease and rising concern over vineyard treatments.

The grape is Voltis, a hybrid developed by researchers at France’s national agricultural institute, INRAE, and the Julius Kühn Institute in Germany. It was approved in 2022 under France’s VIFA framework, which allows new grape varieties to be tested within appellations before any broader adoption. Champagne’s decision to allow it marks a notable shift for a region that has traditionally relied on a narrow set of approved grapes and has been slow to change its rules.

Voltis is not a conventional hybrid in the old sense. It is made up of about 95% Vitis vinifera genetic material, the species associated with classic wine grapes. That detail mattered because French authorities have historically been wary of hybrids in appellation wines. By meeting that threshold, Voltis became eligible for use in Champagne under tightly controlled conditions.

The region’s interest in the grape is tied to practical problems in the vineyard. Champagne’s cool and humid climate makes it especially vulnerable to downy mildew and powdery mildew, two fungal diseases that can damage vines and force growers to spray repeatedly through the season. Those treatments add cost and raise environmental concerns, especially in vineyards near homes or on steep slopes where spraying is more difficult.

Under the new rules, Voltis may be planted on no more than 5% of a vineyard’s surface area and used for up to 10% of a final blend. The limits are meant to keep the grape in an experimental role while preserving the style and identity of Champagne wines. Comité Champagne, the industry group that oversees the appellation, has said Voltis is intended as a complement to existing varieties rather than a replacement for them.

Early trials have given growers reasons to keep testing it. Champagne Drappier planted Voltis vines in 2023 in the Côte des Bar, on Kimmeridgian soils that differ from earlier trial sites near Épernay. The 2025 harvest produced only about 114 liters, but growers reported no visible disease pressure, strong vine vigor and leaves that stayed active later into the season than usual. That longer leaf activity could help vines store more energy for future growth and resilience.

Initial tastings suggest that wines made with Voltis have a fairly neutral aromatic profile. In Champagne, where blending is central to production, that neutrality may be useful rather than limiting. Winemakers often seek grapes that can provide structure without dominating a blend.

The grape also has social implications beyond vineyard science. Some producers have planted it near residential areas to reduce fungicide use and respond to public concern about agricultural spraying. Organic growers may see another benefit as well: Voltis could reduce reliance on copper-based treatments, which remain among the few options allowed against downy mildew but are increasingly scrutinized in France because of environmental concerns.

The Champagne committee has set a 10-year evaluation period for Voltis, signaling that any broader role for the grape will depend on long-term results rather than early enthusiasm alone. Still, interest is growing. In blind tastings held in 2023 with nearly 700 experts, blends containing 5% Voltis were described as rounder, simpler and more approachable.

Around 170 experimental plots have already been planted across cooperatives, major houses and independent growers. Two other disease-resistant varieties, Aurelis and Cérélis, are also under review and could be approved by 2027. At the same time, an initiative called CEPINOV is studying nearly 400 experimental crosses involving Chardonnay and Pinot Noir in search of resistant grapes suited to Champagne and Burgundy.

Even with those changes underway, Champagne continues to protect its traditions closely. In 2025, it reauthorized Chardonnay Rosé, a historic variety that had been excluded because of an administrative oversight. The first commercial Champagnes containing Voltis are expected between 2027 and 2028, giving growers several more years to test how far this new grape can go inside one of wine’s most conservative regions.